Nosocomial transmission, adaption and clinical outcomes of carbapenem-resistant hypervirulent Klebsiella pneumoniae

Background Carbapenem-resistant hypervirulent  Klebsiella pneumoniae  (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial transmission dynamics, adaptive phenotypes, and clinical outcomes of CR-HvKp with different evolutionary patterns. Methods A genom...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:BMC microbiology Ročník 25; číslo 1; s. 376 - 15
Hlavní autori: Liu, Yanjun, Wang, Zhiqian, Jian, Zijuan, Liu, Peilin, Li, Yanming, Qin, Fang, Yan, Qun, Liu, Wenen
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London BioMed Central 02.07.2025
BioMed Central Ltd
Springer Nature B.V
BMC
Predmet:
ISSN:1471-2180, 1471-2180
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Background Carbapenem-resistant hypervirulent  Klebsiella pneumoniae  (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial transmission dynamics, adaptive phenotypes, and clinical outcomes of CR-HvKp with different evolutionary patterns. Methods A genomic analysis of 2,002  Klebsiella pneumoniae  isolates collected from a major teaching hospital in China was performed to identify convergent isolates. Epidemiological features, including CR-HvKp nosocomial transmission, were assessed. Selected isolates underwent phenotypic testing to evaluate adaptive traits. Clinical outcomes were analyzed retrospectively using electronic medical records. Results A total of 127 CR-HvKp were characterized, with ST11-KL64 hv-CRKP (carbapenem resistant  Klebsiella pneumoniae  acquired hypervirulence) as the predominant sequence type. CR-HvKp exhibited diverse evolutionary patterns linked to nosocomial transmission, particularly in the ICU. ST11-KL64 hv-CRKP demonstrated robust transmission within ICU settings. Compared to CRKP, hv-CRKP showed enhanced in vitro competitiveness and superior immune evasion. CR-HvKp infections were significantly associated with higher mortality rates, especially involved in sepsis or septic shock ( P  < 0.0001). Conclusion The ST11-KL64 hv-CRKP clonal complex is highly prevalent in CR-HvKp and demonstrates significant nosocomial transmission, particularly within ICU settings. Timely and effective sepsis management is critical to improving survival outcomes in CR-HvKp infections. Continuous genomic surveillance is imperative to control the spread of these pathogens.
AbstractList Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial transmission dynamics, adaptive phenotypes, and clinical outcomes of CR-HvKp with different evolutionary patterns. A genomic analysis of 2,002 Klebsiella pneumoniae isolates collected from a major teaching hospital in China was performed to identify convergent isolates. Epidemiological features, including CR-HvKp nosocomial transmission, were assessed. Selected isolates underwent phenotypic testing to evaluate adaptive traits. Clinical outcomes were analyzed retrospectively using electronic medical records. A total of 127 CR-HvKp were characterized, with ST11-KL64 hv-CRKP (carbapenem resistant Klebsiella pneumoniae acquired hypervirulence) as the predominant sequence type. CR-HvKp exhibited diverse evolutionary patterns linked to nosocomial transmission, particularly in the ICU. ST11-KL64 hv-CRKP demonstrated robust transmission within ICU settings. Compared to CRKP, hv-CRKP showed enhanced in vitro competitiveness and superior immune evasion. CR-HvKp infections were significantly associated with higher mortality rates, especially involved in sepsis or septic shock (P < 0.0001). The ST11-KL64 hv-CRKP clonal complex is highly prevalent in CR-HvKp and demonstrates significant nosocomial transmission, particularly within ICU settings. Timely and effective sepsis management is critical to improving survival outcomes in CR-HvKp infections. Continuous genomic surveillance is imperative to control the spread of these pathogens.
Background Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial transmission dynamics, adaptive phenotypes, and clinical outcomes of CR-HvKp with different evolutionary patterns. Methods A genomic analysis of 2,002 Klebsiella pneumoniae isolates collected from a major teaching hospital in China was performed to identify convergent isolates. Epidemiological features, including CR-HvKp nosocomial transmission, were assessed. Selected isolates underwent phenotypic testing to evaluate adaptive traits. Clinical outcomes were analyzed retrospectively using electronic medical records. Results A total of 127 CR-HvKp were characterized, with ST11-KL64 hv-CRKP (carbapenem resistant Klebsiella pneumoniae acquired hypervirulence) as the predominant sequence type. CR-HvKp exhibited diverse evolutionary patterns linked to nosocomial transmission, particularly in the ICU. ST11-KL64 hv-CRKP demonstrated robust transmission within ICU settings. Compared to CRKP, hv-CRKP showed enhanced in vitro competitiveness and superior immune evasion. CR-HvKp infections were significantly associated with higher mortality rates, especially involved in sepsis or septic shock (P < 0.0001). Conclusion The ST11-KL64 hv-CRKP clonal complex is highly prevalent in CR-HvKp and demonstrates significant nosocomial transmission, particularly within ICU settings. Timely and effective sepsis management is critical to improving survival outcomes in CR-HvKp infections. Continuous genomic surveillance is imperative to control the spread of these pathogens. Keywords: Carbapenem-resistant hypervirulent Klebsiella pneumoniae, Evolutionary patterns, Nosocomial transmission, Adaptation, Clinical outcomes
Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial transmission dynamics, adaptive phenotypes, and clinical outcomes of CR-HvKp with different evolutionary patterns. A genomic analysis of 2,002 Klebsiella pneumoniae isolates collected from a major teaching hospital in China was performed to identify convergent isolates. Epidemiological features, including CR-HvKp nosocomial transmission, were assessed. Selected isolates underwent phenotypic testing to evaluate adaptive traits. Clinical outcomes were analyzed retrospectively using electronic medical records. A total of 127 CR-HvKp were characterized, with ST11-KL64 hv-CRKP (carbapenem resistant Klebsiella pneumoniae acquired hypervirulence) as the predominant sequence type. CR-HvKp exhibited diverse evolutionary patterns linked to nosocomial transmission, particularly in the ICU. ST11-KL64 hv-CRKP demonstrated robust transmission within ICU settings. Compared to CRKP, hv-CRKP showed enhanced in vitro competitiveness and superior immune evasion. CR-HvKp infections were significantly associated with higher mortality rates, especially involved in sepsis or septic shock (P < 0.0001). The ST11-KL64 hv-CRKP clonal complex is highly prevalent in CR-HvKp and demonstrates significant nosocomial transmission, particularly within ICU settings. Timely and effective sepsis management is critical to improving survival outcomes in CR-HvKp infections. Continuous genomic surveillance is imperative to control the spread of these pathogens.
BackgroundCarbapenem-resistant hypervirulent Klebsiella pneumoniae(CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial transmission dynamics, adaptive phenotypes, and clinical outcomes of CR-HvKp with different evolutionary patterns.MethodsA genomic analysis of 2,002 Klebsiella pneumoniaeisolates collected from a major teaching hospital in China was performed to identify convergent isolates. Epidemiological features, including CR-HvKp nosocomial transmission, were assessed. Selected isolates underwent phenotypic testing to evaluate adaptive traits. Clinical outcomes were analyzed retrospectively using electronic medical records.ResultsA total of 127 CR-HvKp were characterized, with ST11-KL64 hv-CRKP (carbapenem resistant Klebsiella pneumoniaeacquired hypervirulence) as the predominant sequence type. CR-HvKp exhibited diverse evolutionary patterns linked to nosocomial transmission, particularly in the ICU. ST11-KL64 hv-CRKP demonstrated robust transmission within ICU settings. Compared to CRKP, hv-CRKP showed enhanced in vitro competitiveness and superior immune evasion. CR-HvKp infections were significantly associated with higher mortality rates, especially involved in sepsis or septic shock (P < 0.0001).ConclusionThe ST11-KL64 hv-CRKP clonal complex is highly prevalent in CR-HvKp and demonstrates significant nosocomial transmission, particularly within ICU settings. Timely and effective sepsis management is critical to improving survival outcomes in CR-HvKp infections. Continuous genomic surveillance is imperative to control the spread of these pathogens.
Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial transmission dynamics, adaptive phenotypes, and clinical outcomes of CR-HvKp with different evolutionary patterns.BACKGROUNDCarbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial transmission dynamics, adaptive phenotypes, and clinical outcomes of CR-HvKp with different evolutionary patterns.A genomic analysis of 2,002 Klebsiella pneumoniae isolates collected from a major teaching hospital in China was performed to identify convergent isolates. Epidemiological features, including CR-HvKp nosocomial transmission, were assessed. Selected isolates underwent phenotypic testing to evaluate adaptive traits. Clinical outcomes were analyzed retrospectively using electronic medical records.METHODSA genomic analysis of 2,002 Klebsiella pneumoniae isolates collected from a major teaching hospital in China was performed to identify convergent isolates. Epidemiological features, including CR-HvKp nosocomial transmission, were assessed. Selected isolates underwent phenotypic testing to evaluate adaptive traits. Clinical outcomes were analyzed retrospectively using electronic medical records.A total of 127 CR-HvKp were characterized, with ST11-KL64 hv-CRKP (carbapenem resistant Klebsiella pneumoniae acquired hypervirulence) as the predominant sequence type. CR-HvKp exhibited diverse evolutionary patterns linked to nosocomial transmission, particularly in the ICU. ST11-KL64 hv-CRKP demonstrated robust transmission within ICU settings. Compared to CRKP, hv-CRKP showed enhanced in vitro competitiveness and superior immune evasion. CR-HvKp infections were significantly associated with higher mortality rates, especially involved in sepsis or septic shock (P < 0.0001).RESULTSA total of 127 CR-HvKp were characterized, with ST11-KL64 hv-CRKP (carbapenem resistant Klebsiella pneumoniae acquired hypervirulence) as the predominant sequence type. CR-HvKp exhibited diverse evolutionary patterns linked to nosocomial transmission, particularly in the ICU. ST11-KL64 hv-CRKP demonstrated robust transmission within ICU settings. Compared to CRKP, hv-CRKP showed enhanced in vitro competitiveness and superior immune evasion. CR-HvKp infections were significantly associated with higher mortality rates, especially involved in sepsis or septic shock (P < 0.0001).The ST11-KL64 hv-CRKP clonal complex is highly prevalent in CR-HvKp and demonstrates significant nosocomial transmission, particularly within ICU settings. Timely and effective sepsis management is critical to improving survival outcomes in CR-HvKp infections. Continuous genomic surveillance is imperative to control the spread of these pathogens.CONCLUSIONThe ST11-KL64 hv-CRKP clonal complex is highly prevalent in CR-HvKp and demonstrates significant nosocomial transmission, particularly within ICU settings. Timely and effective sepsis management is critical to improving survival outcomes in CR-HvKp infections. Continuous genomic surveillance is imperative to control the spread of these pathogens.
Background Carbapenem-resistant hypervirulent  Klebsiella pneumoniae  (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial transmission dynamics, adaptive phenotypes, and clinical outcomes of CR-HvKp with different evolutionary patterns. Methods A genomic analysis of 2,002  Klebsiella pneumoniae  isolates collected from a major teaching hospital in China was performed to identify convergent isolates. Epidemiological features, including CR-HvKp nosocomial transmission, were assessed. Selected isolates underwent phenotypic testing to evaluate adaptive traits. Clinical outcomes were analyzed retrospectively using electronic medical records. Results A total of 127 CR-HvKp were characterized, with ST11-KL64 hv-CRKP (carbapenem resistant  Klebsiella pneumoniae  acquired hypervirulence) as the predominant sequence type. CR-HvKp exhibited diverse evolutionary patterns linked to nosocomial transmission, particularly in the ICU. ST11-KL64 hv-CRKP demonstrated robust transmission within ICU settings. Compared to CRKP, hv-CRKP showed enhanced in vitro competitiveness and superior immune evasion. CR-HvKp infections were significantly associated with higher mortality rates, especially involved in sepsis or septic shock ( P  < 0.0001). Conclusion The ST11-KL64 hv-CRKP clonal complex is highly prevalent in CR-HvKp and demonstrates significant nosocomial transmission, particularly within ICU settings. Timely and effective sepsis management is critical to improving survival outcomes in CR-HvKp infections. Continuous genomic surveillance is imperative to control the spread of these pathogens.
Abstract Background Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial transmission dynamics, adaptive phenotypes, and clinical outcomes of CR-HvKp with different evolutionary patterns. Methods A genomic analysis of 2,002 Klebsiella pneumoniae isolates collected from a major teaching hospital in China was performed to identify convergent isolates. Epidemiological features, including CR-HvKp nosocomial transmission, were assessed. Selected isolates underwent phenotypic testing to evaluate adaptive traits. Clinical outcomes were analyzed retrospectively using electronic medical records. Results A total of 127 CR-HvKp were characterized, with ST11-KL64 hv-CRKP (carbapenem resistant Klebsiella pneumoniae acquired hypervirulence) as the predominant sequence type. CR-HvKp exhibited diverse evolutionary patterns linked to nosocomial transmission, particularly in the ICU. ST11-KL64 hv-CRKP demonstrated robust transmission within ICU settings. Compared to CRKP, hv-CRKP showed enhanced in vitro competitiveness and superior immune evasion. CR-HvKp infections were significantly associated with higher mortality rates, especially involved in sepsis or septic shock (P < 0.0001). Conclusion The ST11-KL64 hv-CRKP clonal complex is highly prevalent in CR-HvKp and demonstrates significant nosocomial transmission, particularly within ICU settings. Timely and effective sepsis management is critical to improving survival outcomes in CR-HvKp infections. Continuous genomic surveillance is imperative to control the spread of these pathogens.
ArticleNumber 376
Audience Academic
Author Liu, Wenen
Liu, Peilin
Li, Yanming
Yan, Qun
Qin, Fang
Liu, Yanjun
Jian, Zijuan
Wang, Zhiqian
Author_xml – sequence: 1
  givenname: Yanjun
  surname: Liu
  fullname: Liu, Yanjun
  organization: Department of Clinical Laboratory, Xiangya Hospital, Central South University
– sequence: 2
  givenname: Zhiqian
  surname: Wang
  fullname: Wang, Zhiqian
  organization: Department of Clinical Laboratory, Xiangya Hospital, Central South University
– sequence: 3
  givenname: Zijuan
  surname: Jian
  fullname: Jian, Zijuan
  organization: Department of Clinical Laboratory, Xiangya Hospital, Central South University
– sequence: 4
  givenname: Peilin
  surname: Liu
  fullname: Liu, Peilin
  organization: Department of Clinical Laboratory, Xiangya Hospital, Central South University
– sequence: 5
  givenname: Yanming
  surname: Li
  fullname: Li, Yanming
  organization: Department of Clinical Laboratory, Xiangya Hospital, Central South University
– sequence: 6
  givenname: Fang
  surname: Qin
  fullname: Qin, Fang
  organization: Department of Clinical Laboratory, Xiangya Hospital, Central South University
– sequence: 7
  givenname: Qun
  surname: Yan
  fullname: Yan, Qun
  organization: Department of Clinical Laboratory, Xiangya Hospital, Central South University
– sequence: 8
  givenname: Wenen
  surname: Liu
  fullname: Liu, Wenen
  email: wenenliu@163.com
  organization: Department of Clinical Laboratory, Xiangya Hospital, Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40597682$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1DAYhSNURC_wAixQJDYgkeJL4tgrVFVcRq2KxGVtOfafqUeJndpORfs0PAtPhqdT2g5CKItY9neO_R-d_WLHeQdF8RyjQ4w5exsx4YxViDQVqpFg1fWjYg_XLa4I5mjnwXq32I9xhRBuOW2fFLs1akTLONkr0pmPXvvRqqFMQbk42hitd29KZdSU8qpUzpR6sM7qzPg5ZRpi6ftSq9CpCRyMVYBoY1IuledXE4RLG-YBXPr182SALloYBlVODubRO6vgafG4V0OEZ7f_g-L7h_ffjj9Vp58_Lo6PTivdiCZVjWDQGehr1kIeFFPOjG46xEULinUCDDR1a5ighHOloMMM9YoRwzpKGQV6UCw2vsarlZyCHVW4kl5ZebPhw1KqkKweQBrW0OyuKcFQE4I46oQmdU94RxAmOnu923hNczeC0Xm6oIYt0-0TZ8_l0l9KTAgWAtfZ4dWtQ_AXM8Qkc9Z6HY0DP0dJCWG0EahBGX35F7ryc3A5qzXVsroRgt1TS5UnsK73-WK9NpVHvGZE5JevqcN_UPkzMFqdG9XbvL8leL0lyEyCH2mp5hjl4uuXbfbFw1Tu4vhTsAyQDaCDjzFAf4dgJNctlpsWy9xiedNieZ1FdCOKGXZLCPfj_0f1G2iJ9gI
Cites_doi 10.1128/aac
10.1038/s41564-024-01612-1
10.1099/mgen.0.000196
10.1080/22221751.2022.2103454
10.3389/fcimb.2020.556654
10.1093/jac/dkac326
10.1016/j.jiph.2019.11.014
10.1016/j.bioactmat.2024.04.01
10.3389/fmicb.2023.1181701
10.1016/s1473-3099(21)00399-6
10.2147/idr.S428067
10.1016/j.ijantimicag.2023.107055
10.3389/fcimb.
10.1111/j.1469-0691.2011.03570.x
10.1038/s41467-023-43802-1
10.1128/jcm.00776-18
10.1128/aac.01675-19
10.1093/cid/ciac354
10.4103/jms.jms_25_17
10.1093/jac/dkaa345
10.1016/j.scitotenv.
10.1128/aac.01424-22
10.2147/idr.S442454
10.1016/j.jhin.2018.10.014
10.1002/jcla.24743
10.1016/j.watres.2023.120263
10.1128/spectrum.02698-21
10.1016/j.scib.2023
10.2147/idr.S353858
10.1080/22221751.2022.2140607
10.1128/msystems.01363-23
10.1016/s2666-5247
10.3389/fcimb.2023.1108818
10.1093/nar/gkw290
10.1080/21505594.2021.1960101
10.1038/s41467-021-24448-3
10.3389/fpubh.2019.00229
10.1038/s41467-023-44351-3
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7QL
7T7
7U9
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12866-025-04096-z
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE



Publicly Available Content Database
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1471-2180
EndPage 15
ExternalDocumentID oai_doaj_org_article_d6536dcc321e422080b9c24f28b2012c
PMC12219914
A846292016
40597682
10_1186_s12866_025_04096_z
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: National Key Research and Development Program of China
  grantid: 2018YFC2000203; 2018YFC2000203; 2018YFC2000203; 2018YFC2000203; 2018YFC2000203; 2018YFC2000203; 2018YFC2000203; 2018YFC2000203
  funderid: https://doi.org/10.13039/501100012166
– fundername: National Key Research and Development Program of China
  grantid: 2018YFC2000203
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESTFP
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ISR
ITC
KQ8
LK5
LK8
M1P
M7P
M7R
MM.
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~02
AAYXX
AFFHD
CITATION
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7T7
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
M48
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c595t-596ebdef467e8661386dc5b0897ea6b9ede547d693288aaeb160fa62d6b3363e3
IEDL.DBID DOA
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001521262400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1471-2180
IngestDate Fri Oct 03 12:50:59 EDT 2025
Tue Nov 04 02:04:51 EST 2025
Fri Sep 05 15:46:20 EDT 2025
Wed Oct 08 14:20:51 EDT 2025
Sat Nov 29 13:48:29 EST 2025
Mon Nov 24 15:47:54 EST 2025
Mon Nov 24 14:51:19 EST 2025
Sat Jul 05 01:30:49 EDT 2025
Sat Nov 29 07:51:57 EST 2025
Sat Sep 06 07:25:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Nosocomial transmission
Carbapenem-resistant hypervirulent
Evolutionary patterns
Clinical outcomes
Adaptation
Carbapenem-resistant hypervirulent Klebsiella pneumoniae
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c595t-596ebdef467e8661386dc5b0897ea6b9ede547d693288aaeb160fa62d6b3363e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/d6536dcc321e422080b9c24f28b2012c
PMID 40597682
PQID 3227645996
PQPubID 42585
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_d6536dcc321e422080b9c24f28b2012c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12219914
proquest_miscellaneous_3226359050
proquest_journals_3227645996
gale_infotracmisc_A846292016
gale_infotracacademiconefile_A846292016
gale_incontextgauss_ISR_A846292016
pubmed_primary_40597682
crossref_primary_10_1186_s12866_025_04096_z
springer_journals_10_1186_s12866_025_04096_z
PublicationCentury 2000
PublicationDate 2025-07-02
PublicationDateYYYYMMDD 2025-07-02
PublicationDate_xml – month: 07
  year: 2025
  text: 2025-07-02
  day: 02
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC microbiology
PublicationTitleAbbrev BMC Microbiol
PublicationTitleAlternate BMC Microbiol
PublicationYear 2025
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References D Pu (4096_CR8) 2023; 68
AP Magiorakos (4096_CR13) 2012; 18
D Tian (4096_CR3) 2022; 11
A Carattoli (4096_CR16) 2014; 58
YL Wu (4096_CR36) 2019; 101
H Heng (4096_CR6) 2024; 63
MJ Satlin (4096_CR20) 2022; 75
O Hallal Ferreira Raro (4096_CR31) 2023; 67
4096_CR34
H Chang (4096_CR38) 2020; 13
M Wang (4096_CR2) 2022; 22
M Dong (4096_CR32) 2024; 17
4096_CR11
4096_CR14
S Wei (4096_CR39) 2023; 12
M Biedrzycka (4096_CR30) 2022; 77
Y Zhao (4096_CR9) 2019; 7
TJ Kochan (4096_CR12) 2023; 14
4096_CR18
4096_CR19
V Bortolaia (4096_CR15) 2020; 75
P Liu (4096_CR25) 2023; 14
I Letunic (4096_CR22) 2016; 44
R Wang (4096_CR28) 2024; 15
CL Gorrie (4096_CR23) 2021; 2
S Shrivastava (4096_CR1) 2018; 32
G Teng (4096_CR37) 2024; 9
FL Du (4096_CR10) 2020; 10
Y Liu (4096_CR21) 2023; 16
Y Zhang (4096_CR26) 2022; 15
MMC Lam (4096_CR17) 2021; 12
P Dai (4096_CR4) 2022; 36
H Zou (4096_CR5) 2023; 242
C Liu (4096_CR29) 2023; 889
4096_CR40
Q Xu (4096_CR27) 2021; 12
L Zeng (4096_CR35) 2021; 11
N Pei (4096_CR24) 2022; 10
W Wang (4096_CR33) 2023; 13
F Hu (4096_CR7) 2024; 9
References_xml – volume: 58
  start-page: 3895
  issue: 7
  year: 2014
  ident: 4096_CR16
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/aac
– volume: 9
  start-page: 814
  issue: 3
  year: 2024
  ident: 4096_CR7
  publication-title: Nat Microbiol
  doi: 10.1038/s41564-024-01612-1
– ident: 4096_CR14
  doi: 10.1099/mgen.0.000196
– volume: 11
  start-page: 1936
  issue: 1
  year: 2022
  ident: 4096_CR3
  publication-title: Emerg Microbes Infect
  doi: 10.1080/22221751.2022.2103454
– ident: 4096_CR19
– volume: 10
  start-page: 556654
  year: 2020
  ident: 4096_CR10
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2020.556654
– volume: 77
  start-page: 3367
  issue: 12
  year: 2022
  ident: 4096_CR30
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkac326
– volume: 13
  start-page: 784
  issue: 5
  year: 2020
  ident: 4096_CR38
  publication-title: J Infect Public Health
  doi: 10.1016/j.jiph.2019.11.014
– ident: 4096_CR40
  doi: 10.1016/j.bioactmat.2024.04.01
– volume: 14
  start-page: 1181701
  year: 2023
  ident: 4096_CR25
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2023.1181701
– volume: 22
  start-page: 401
  issue: 3
  year: 2022
  ident: 4096_CR2
  publication-title: Lancet Infect Dis
  doi: 10.1016/s1473-3099(21)00399-6
– volume: 16
  start-page: 7597
  year: 2023
  ident: 4096_CR21
  publication-title: Infect Drug Resist
  doi: 10.2147/idr.S428067
– volume: 63
  start-page: 107055
  issue: 2
  year: 2024
  ident: 4096_CR6
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2023.107055
– volume: 11
  start-page: 656070
  year: 2021
  ident: 4096_CR35
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.
– volume: 18
  start-page: 268
  issue: 3
  year: 2012
  ident: 4096_CR13
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2011.03570.x
– volume: 14
  start-page: 7962
  issue: 1
  year: 2023
  ident: 4096_CR12
  publication-title: Nat Commun
  doi: 10.1038/s41467-023-43802-1
– ident: 4096_CR11
  doi: 10.1128/jcm.00776-18
– ident: 4096_CR34
  doi: 10.1128/aac.01675-19
– volume: 75
  start-page: 2066
  issue: 12
  year: 2022
  ident: 4096_CR20
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciac354
– volume: 32
  start-page: 76
  issue: 1
  year: 2018
  ident: 4096_CR1
  publication-title: J Med Soc.
  doi: 10.4103/jms.jms_25_17
– volume: 75
  start-page: 3491
  issue: 12
  year: 2020
  ident: 4096_CR15
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkaa345
– volume: 889
  start-page: 164302
  year: 2023
  ident: 4096_CR29
  publication-title: Sci Total Environ
  doi: 10.1016/j.scitotenv.
– ident: 4096_CR18
– volume: 67
  start-page: e0142422
  issue: 3
  year: 2023
  ident: 4096_CR31
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/aac.01424-22
– volume: 17
  start-page: 283
  year: 2024
  ident: 4096_CR32
  publication-title: Infect Drug Resist
  doi: 10.2147/idr.S442454
– volume: 101
  start-page: 231
  issue: 2
  year: 2019
  ident: 4096_CR36
  publication-title: J Hosp Infect
  doi: 10.1016/j.jhin.2018.10.014
– volume: 36
  start-page: e24743
  issue: 12
  year: 2022
  ident: 4096_CR4
  publication-title: J Clin Lab Anal
  doi: 10.1002/jcla.24743
– volume: 242
  start-page: 120263
  year: 2023
  ident: 4096_CR5
  publication-title: Water Res
  doi: 10.1016/j.watres.2023.120263
– volume: 10
  start-page: e0269821
  issue: 2
  year: 2022
  ident: 4096_CR24
  publication-title: Microbiol Spectr
  doi: 10.1128/spectrum.02698-21
– volume: 68
  start-page: 2658
  issue: 21
  year: 2023
  ident: 4096_CR8
  publication-title: Sci Bull (Beijing)
  doi: 10.1016/j.scib.2023
– volume: 15
  start-page: 1487
  year: 2022
  ident: 4096_CR26
  publication-title: Infect Drug Resist
  doi: 10.2147/idr.S353858
– volume: 12
  start-page: 2140607
  issue: 1
  year: 2023
  ident: 4096_CR39
  publication-title: Emerg Microbes Infect
  doi: 10.1080/22221751.2022.2140607
– volume: 9
  start-page: e0136323
  issue: 6
  year: 2024
  ident: 4096_CR37
  publication-title: mSystems
  doi: 10.1128/msystems.01363-23
– volume: 2
  start-page: e575
  issue: 11
  year: 2021
  ident: 4096_CR23
  publication-title: Lancet Microbe
  doi: 10.1016/s2666-5247
– volume: 13
  start-page: 1108818
  year: 2023
  ident: 4096_CR33
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2023.1108818
– volume: 44
  start-page: W242
  issue: W1
  year: 2016
  ident: 4096_CR22
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkw290
– volume: 12
  start-page: 2050
  issue: 1
  year: 2021
  ident: 4096_CR27
  publication-title: Virulence
  doi: 10.1080/21505594.2021.1960101
– volume: 12
  start-page: 4188
  issue: 1
  year: 2021
  ident: 4096_CR17
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-24448-3
– volume: 7
  start-page: 229
  year: 2019
  ident: 4096_CR9
  publication-title: Front Public Health
  doi: 10.3389/fpubh.2019.00229
– volume: 15
  start-page: 67
  issue: 1
  year: 2024
  ident: 4096_CR28
  publication-title: Nat Commun
  doi: 10.1038/s41467-023-44351-3
SSID ssj0017837
Score 2.4420075
Snippet Background Carbapenem-resistant hypervirulent  Klebsiella pneumoniae  (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the...
Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial...
Background Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the...
BackgroundCarbapenem-resistant hypervirulent Klebsiella pneumoniae(CR-HvKp) poses a significant threat in healthcare settings. This study investigates the...
Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-HvKp) poses a significant threat in healthcare settings. This study investigates the nosocomial...
Abstract Background Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-HvKp) poses a significant threat in healthcare settings. This study...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 376
SubjectTerms Adaptation
Aged
Anti-Bacterial Agents - pharmacology
Antibiotics
Antigens
Antimicrobial agents
Bacteria
Biofilms
Biological Microscopy
Biomedical and Life Sciences
Carbapenem-Resistant Enterobacteriaceae - drug effects
Carbapenem-Resistant Enterobacteriaceae - genetics
Carbapenem-Resistant Enterobacteriaceae - isolation & purification
Carbapenem-Resistant Enterobacteriaceae - pathogenicity
Carbapenem-resistant hypervirulent Klebsiella pneumoniae
Carbapenems
Carbapenems - pharmacology
Care and treatment
China - epidemiology
Clinical outcomes
Competitiveness
Control
Cross infection
Cross Infection - epidemiology
Cross Infection - microbiology
Cross Infection - transmission
Diagnosis
Disease transmission
Drug resistance
Electronic health records
Electronic medical records
Epidemiology
Evolution & development
Evolutionary patterns
Female
Genes
Genomes
Genomic analysis
Hospitals
Humans
Identification and classification
Infections
Intensive Care Units
Klebsiella
Klebsiella Infections - drug therapy
Klebsiella Infections - epidemiology
Klebsiella Infections - microbiology
Klebsiella Infections - mortality
Klebsiella Infections - transmission
Klebsiella pneumoniae
Klebsiella pneumoniae - classification
Klebsiella pneumoniae - drug effects
Klebsiella pneumoniae - genetics
Klebsiella pneumoniae - isolation & purification
Klebsiella pneumoniae - pathogenicity
Laboratory animals
Life Sciences
Male
Maximum likelihood method
Microbial Sensitivity Tests
Microbiology
Middle Aged
Mortality
Mycology
Neutrophils
Nosocomial infection
Nosocomial infections
Nosocomial transmission
Parasitology
Phenotypes
Phylogenetics
Plasmids
Prevention
Retrospective Studies
Risk factors
Sepsis
Septic shock
Virology
Virulence
SummonAdditionalLinks – databaseName: Biological Science Database
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaggMSFdyFQkEFIHGjUrJP4cUIFUYFAq4qH1JvlV9qVaLJsEiT665nxJltSBBeu8USyPZ9nPtvjGUKeG664UlWVepFVaSHBDipvVBpY5rD-VAghpsz_KOZzeXSkDocDt3YIqxxtYjTUvnF4Rr4HwBOY-ETxV8vvKVaNwtvVoYTGZXIFsySwGLp3uLlFELD7Gh_KSL7Xgi3mGHJbpgBdxdOziTOKOfv_tMy_uaaLYZMX7k6jSzq4-b-DuUVuDGSU7q_Rc5tcCvUdcm1dnvLnXdLOG9BdcwoQpR36NMAEHq7tUuNNNDXU1J6Ojytp03cgHVraVNThPcYSDOlpCht6JKl1R09g0wumadWjq6MfvgXbLjD6ii7r0EOfFibcI18P3n558y4dijSkrlRll5aKB-tDBQY3wOzOcsm9K20mlQiGWxV8KAvhOfBEKY0B18CzynDmuc1znod8m2zVTR0eEOqtEKUXlRUOWRxQKSO5zbAktvG2KBLyctSWXq5zcei4h5Fcr3WrQbc66lafJeQ1KnQjiXm044dmdayHZak9L3Por8vZLBSMAX22yrGiYtICM2IuIc8QDhozZdQYinNs-rbV7z9_0vvA3LDU14wn5MUgVDWgDWeGlw0wKkyuNZHcmUiC2ty0eYSLHkxJq8-xkpCnm2b8ExVUh6aPMkAcVVZmCbm_Bulm3MDIgXJKlhA5ge9kYqYt9eIkJhqfMYaRcTDxuyPSz_v195l_-O9hPCLXWVyDApbiDtnqVn14TK66H92iXT2JK_gXmwVQwg
  priority: 102
  providerName: ProQuest
– databaseName: SpringerLINK Contemporary 1997-Present
  dbid: RSV
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaggMSF9yNQkEFIHGhE1kn8OBZEBQKtUAuoN8uvtCvRZLVJkOiv4bfwy5jxJgspcIBrPJHimfE3n-PxDCFPDFdcqapKvciqtJCAg8oblQaWOew_FUKIJfPfiflcHh6q98OlsHbMdh-PJCNSx2Ut-fMWkJRjwmyZguMpnp6eJxcg3Els2LB_8GlzdiBgzzVej_nje5MQFCv1_47HvwSks8mSZ05MYyDau_p_U7hGrgzEk-6uPeU6ORfqG-TSuhXl15ukmzdgp-YE3JF2GL_A_vgjbYcabyKsUFN7Ol6kpE3fgXRoaVNRh2cWSwDNkxQ270hI644ewwYXYGjVY1j7_u3t52DbBaZa0WUdenD-hQm3yMe9Vx9evk6HjgypK1XZpaXiwfpQAboGmMksl9y70mZSiWC4VcGHshCeAymU0hiIAzyrDGee2zznechvk626qcNdQr0VovSissIhZQPeZCS3Gfa_Nt4WRUKejUbSy3XhDR03LJLrtR416FFHPerThLxAO24ksWh2fNCsjvSwBrXnZQ7f63I2CwVjwJWtcqyomLRAg5hLyGP0Ao1lMWrMuzkyfdvqNwf7ehdoGvb1mvGEPB2EqgbM4cxwjQFmhZW0JpLbE0mwm5sOj86mB9xoNcCrwPI-CoYfbYbxTTRQHZo-ygBLVFmZJeTO2jc38wb6DfxSsoTIiddOFDMdqRfHsar4jDFMgwPF74zO-_O7_q75e_8mfp9cZtH_BSyDbbLVrfrwgFx0X7pFu3oYF_IP_zpI5A
  priority: 102
  providerName: Springer Nature
Title Nosocomial transmission, adaption and clinical outcomes of carbapenem-resistant hypervirulent Klebsiella pneumoniae
URI https://link.springer.com/article/10.1186/s12866-025-04096-z
https://www.ncbi.nlm.nih.gov/pubmed/40597682
https://www.proquest.com/docview/3227645996
https://www.proquest.com/docview/3226359050
https://pubmed.ncbi.nlm.nih.gov/PMC12219914
https://doaj.org/article/d6536dcc321e422080b9c24f28b2012c
Volume 25
WOSCitedRecordID wos001521262400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMed Central Open Access Free
  customDbUrl:
  eissn: 1471-2180
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017837
  issn: 1471-2180
  databaseCode: RBZ
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1471-2180
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017837
  issn: 1471-2180
  databaseCode: DOA
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1471-2180
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017837
  issn: 1471-2180
  databaseCode: M~E
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1471-2180
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017837
  issn: 1471-2180
  databaseCode: M7P
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1471-2180
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017837
  issn: 1471-2180
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1471-2180
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017837
  issn: 1471-2180
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1471-2180
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017837
  issn: 1471-2180
  databaseCode: PIMPY
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1471-2180
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017837
  issn: 1471-2180
  databaseCode: RSV
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELaggMQF8U-grAJC4kCjZp3EP8cWtaICVqstoHKyHNuhK9FktUmQ6NPwLDwZM06yNEWIC5dIG0-kZGb8zef1eIaQF5pJJmVRRJbHRZQKwEFptYwcjQ32n3LO-ZL57_hsJk5O5PxCqy_MCevKA3eK27UsS5g1JqFTl1IKBCeXhqYFFTnELmoQfWMuh8VUv3_AYd01HJERbLcGFGaYbJtF4LSSReejMOSr9f-JyReC0uWEyUu7pj4YHd4mt3oWGe51b3-HXHHlXXKj6yv5_R5pZhUovToD3wobDEZgTPxXbCfUVnuMCHVpw-FUZFi1DUi7OqyK0OAGxAoQ8CyClTiyy7IJT2G1CpiybjFG_fzx9qvL6yXmTYWr0rXgyUvt7pOPhwcfXr-J-vYKkclk1kSZZC63rgCodKCdaSJAz1keC8mdZrl01mUptwwYnhBaA6izuNCMWpYnCUtc8oBslVXpHpHQ5pxnlhc5N8i_gARpwfIYm1lrm6dpQF4N2larroqG8qsPwVRnGwW2Ud426jwg-2iQjSRWwPY3wC9U7xfqX34RkOdoToU1LkpMovmi27pWR8cLtQecC5t0TVlAXvZCRQXmMLo_kwBfhWWxRpLbI0mwmxkPD16jehCoFWAlx1o9EoafbYbxSTRQ6arWywDlk3EWB-Rh52Sb7wYuDWRR0ICIkfuNFDMeKZenvkT4lFLMaQPF7wye-vu9_q75x_9D80_ITepnGocJt022mnXrnpLr5luzrNcTcpWfcH8VE3Jt_2A2X0z83J1g2u0c7s2P3s8_w6_F8adf7d9KKg
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELbKFgQX3o9AAYNAHGjUrJM49gGh8qi62u2qgiKVk3Fip12JJssmAbU_it_ITB5bUgS3HriuJ6vY_uabmXg8Q8gzzSWXMk1dE3mpGwjgQWm0dC3zEuw_Za2tS-ZPoulU7O_L3RXys7sLg2mVHSfWRG3yBL-RbwDwIix8Ivnr-TcXu0bh6WrXQqOBxdge_4CQrXg1egf7-5yxrfd7b7fdtquAm4QyLN1QchsbmwJDWAHWyRfcJGHsCRlZzWNpjQ2DyHBwbITQGriMe6nmzPDY97lvffjfC2Q1QLAPyOruaGf38_LcIoJ4r7uaI_hGAezPMck3dEFZJHdPeuav7hLwpy34zRieTdQ8c1pbG8Gta__b8l0nV1t3m242-nGDrNjsJrnUNOA8vkWKaQ7ozI9ACWmJVhtQj58P16k2uiZTqjNDu-ujNK9KkLYFzVOa4EnNHEzFkbuwBbrhWUkPIawH8l1UaMzp-KuNixnml9F5ZitYg5m2t8mnc5nxHTLI8szeI9TEURSaKI2jBP1UcBa14LGHTb-1iYPAIS87dKh5U21E1VGa4KrBkgIsqRpL6sQhbxBAS0msFF7_kC8OVEs8yvDQh_dNfDa0AWMQIMQyYUHKRAy-H0sc8hThp7AWSIbJRge6Kgo1-vhBbYJvis3MhtwhL1qhNIfdSHR7dwNmheXDepJrPUnYtqQ_3MFTtWRZqFNsOuTJchifxA3KbF7VMuAaSy_0HHK3UYrlvCHmAKdaMIeInrr0FqY_ks0O61LqQ8Yw9w8Wfr3TrNP3-vvK3__3NB6Ty9t7OxM1GU3HD8gVVut_BDSwRgblorIPycXkezkrFo9a_qDky3nr3C_5j6_u
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFLagLOLCTgkUMAiJA42acRLHPpZlRNVqVFFAvVmO7bQjtclokiDRX8Nv4ZfxnpMMTYED4hq_SPFbP8dvIeSl5pJLWRShzaIiTAT4QWm1DB2LDM6fcs75lvl72WwmDg_l_rkqfp_tPlxJdjUN2KWpbLYWtuhMXPCtGrwqx-TZNAQllDw8u0yuJJhIj-f1gy-re4QMzl9Dqcwf3xuFI9-1_3fffC44XUycvHB76oPS9Nb_b-c2udkDUrrdadAdcsmVd8m1bkTlt3ukmVUgv-oU1JQ2GNdAL_AH2ybVVnt3Q3Vp6VBgSau2AWpX06qgBu8yFuBMT0M41CNQLRt6DAdfcE_LFsPdj--7Jy6v55iCRRela8Eo5trdJ5-n7z-9_RD2kxpCk8q0CVPJXW5dAV7XwU4mseDWpHkkZOY0z6WzLk0yywEsCqE1xAceFZozy_M45rGLH5C1sirdQ0JtnmWpzYo8MwjlAE9pwfMI52JrmydJQF4PAlOLriGH8gcZwVXHRwV8VJ6P6iwgb1CmK0pspu0fVMsj1dumsjyN4XtNzCYuYQwwdC4NSwomcoBHzATkBWqEwnYZJebjHOm2rtXOwUe1DfAN531NeEBe9URFBeIwui9vgF1hh60R5caIEuRmxsuD4qnen9QK3G6GbX8kLD9fLeObKKDSVa2nAfQoozQKyHqnp6t9AywH3ClYQMRIg0eMGa-U82PfbXzCGKbHAeM3B0X-9V1_5_yjfyN_Rq7vv5uqvZ3Z7mNyg3lTyMAiNshas2zdE3LVfG3m9fKpt--fYS1UrA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nosocomial+transmission%2C+adaption+and+clinical+outcomes+of+carbapenem-resistant+hypervirulent%C2%A0Klebsiella+pneumoniae&rft.jtitle=BMC+microbiology&rft.au=Liu%2C+Yanjun&rft.au=Wang%2C+Zhiqian&rft.au=Jian%2C+Zijuan&rft.au=Liu%2C+Peilin&rft.date=2025-07-02&rft.eissn=1471-2180&rft.volume=25&rft.issue=1&rft.spage=376&rft_id=info:doi/10.1186%2Fs12866-025-04096-z&rft_id=info%3Apmid%2F40597682&rft.externalDocID=40597682
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2180&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2180&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2180&client=summon